PDCD1LG2 and non-small cell lung carcinoma: Anti-PD-1 is sometimes effective in patients with non-small cell lung cancer, regardless of low PD-L1 expression, in which case it is a strong possibility that PD-L2 was highly expressed in the tumor mass.